Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Lingeman

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
BJU International|April 26, 2018
WATER II (80-150 mL) procedural outcomesMihir Desai, Mo Bidair, Naeem Bhojani, et al.
BJU International|February 9, 2019
Aquablation for benign prostatic hyperplasia in large prostates (80-150 mL): 6-month results from the WATER II trialMihir Desai, Mo Bidair, Kevin C Zorn, et al.
Urology|May 7, 2019
Aquablation for Benign Prostatic Hyperplasia in Large Prostates (80-150 cc): 1-Year ResultsNaeem Bhojani, Mohamed Bidair, Kevin C Zorn, et al.
BJUI Compass|April 27, 2022
Aquablation therapy in large prostates (80-150 cc) for lower urinary tract symptoms due to benign prostatic hyperplasia: WATER II 3-year trial resultsKevin C Zorn, Mohamed Bidair, Andrew Trainer, et al.
The Canadian Journal of Urology|April 26, 2020
Aquablation for benign prostatic hyperplasia in large prostates (80-150 cc): 2-year resultsMihir Desai, Mo Bidair, Naeem Bhojani, et al.
Journal of Nephrology|July 27, 2016
Metabolic diagnosis and medical prevention of calcium nephrolithiasis and its systemic manifestations: a consensus statementGiovanni Gambaro, Emanuele Croppi, Fredric Coe, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
BJU International|April 26, 2018
WATER II (80-150 mL) procedural outcomesMihir Desai, Mo Bidair, Naeem Bhojani, et al.
BJU International|February 9, 2019
Aquablation for benign prostatic hyperplasia in large prostates (80-150 mL): 6-month results from the WATER II trialMihir Desai, Mo Bidair, Kevin C Zorn, et al.
Urology|May 7, 2019
Aquablation for Benign Prostatic Hyperplasia in Large Prostates (80-150 cc): 1-Year ResultsNaeem Bhojani, Mohamed Bidair, Kevin C Zorn, et al.
BJUI Compass|April 27, 2022
Aquablation therapy in large prostates (80-150 cc) for lower urinary tract symptoms due to benign prostatic hyperplasia: WATER II 3-year trial resultsKevin C Zorn, Mohamed Bidair, Andrew Trainer, et al.
The Canadian Journal of Urology|April 26, 2020
Aquablation for benign prostatic hyperplasia in large prostates (80-150 cc): 2-year resultsMihir Desai, Mo Bidair, Naeem Bhojani, et al.
Journal of Nephrology|July 27, 2016
Metabolic diagnosis and medical prevention of calcium nephrolithiasis and its systemic manifestations: a consensus statementGiovanni Gambaro, Emanuele Croppi, Fredric Coe, et al.
Pageof 2